Relapsing Prostate Cancer: Castrate or Cure?

A 62-year-old man presented with nocturia and urinary frequency and was found to have an elevated prostate-specific antigen level of 14.2  μg/L. Diagnostic magnetic resonance imaging of the pelvis and prostate showed a T2c prostate tumor, and transrectal ultrasound-guided biopsy findings confirmed a group 4 prostate adenocarcinoma according to the Gleason grade. A radioisotope bone scan confirmed no evidence of bone metastases. The patient received neoadjuvant androgen deprivation therapy (ADT) followed by radical radiation therapy to the prostate to a dose of 60 Gy in 20 fractions. The pelvic nodes were not treated.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Tags: Gray Zone Source Type: research